Rigel Pharmaceuticals Stock Forward View - Accumulation Distribution
| RIGL Stock | USD 35.16 0.09 0.26% |
Rigel Stock outlook is based on your current time horizon. Although Rigel Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Rigel Pharmaceuticals' systematic risk associated with finding meaningful patterns of Rigel Pharmaceuticals fundamentals over time.
As of now, the RSI of Rigel Pharmaceuticals' share price is approaching 45 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Rigel Pharmaceuticals, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.086 | EPS Estimate Next Quarter 0.8 | EPS Estimate Current Year 6.6903 | EPS Estimate Next Year 3.7177 | Wall Street Target Price 51.6 |
Using Rigel Pharmaceuticals hype-based prediction, you can estimate the value of Rigel Pharmaceuticals from the perspective of Rigel Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Rigel Pharmaceuticals using Rigel Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Rigel using crowd psychology based on the activity and movement of Rigel Pharmaceuticals' stock price.
Rigel Pharmaceuticals Short Interest
An investor who is long Rigel Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Rigel Pharmaceuticals and may potentially protect profits, hedge Rigel Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 30.3736 | Short Percent 0.2094 | Short Ratio 6.44 | Shares Short Prior Month 3.4 M | 50 Day MA 42.6562 |
Rigel Relative Strength Index
Rigel Pharmaceuticals Hype to Price Pattern
Investor biases related to Rigel Pharmaceuticals' public news can be used to forecast risks associated with an investment in Rigel. The trend in average sentiment can be used to explain how an investor holding Rigel can time the market purely based on public headlines and social activities around Rigel Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Rigel Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Rigel Pharmaceuticals.
Rigel Pharmaceuticals Implied Volatility | 1.34 |
Rigel Pharmaceuticals' implied volatility exposes the market's sentiment of Rigel Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Rigel Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Rigel Pharmaceuticals stock will not fluctuate a lot when Rigel Pharmaceuticals' options are near their expiration.
Rigel Pharmaceuticals after-hype prediction price | USD 35.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Rigel Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Rigel contract
Based on the Rule 16, the options market is currently suggesting that Rigel Pharmaceuticals will have an average daily up or down price movement of about 0.0838% per day over the life of the 2026-03-20 option contract. With Rigel Pharmaceuticals trading at USD 35.16, that is roughly USD 0.0294 . If you think that the market is fully incorporating Rigel Pharmaceuticals' daily price movement you should consider acquiring Rigel Pharmaceuticals options at the current volatility level of 1.34%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Rigel Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Rigel Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Rigel Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Rigel Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Rigel Pharmaceuticals' open interest, investors have to compare it to Rigel Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Rigel Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Rigel. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Rigel Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Rigel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rigel using various technical indicators. When you analyze Rigel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 22874.86 | 11564.07 |
| Check Rigel Pharmaceuticals Volatility | Backtest Rigel Pharmaceuticals | Information Ratio |
Rigel Pharmaceuticals Trading Date Momentum
| On January 29 2026 Rigel Pharmaceuticals was traded for 35.16 at the closing time. The top price for the day was 35.94 and the lowest listed price was 34.72 . The trading volume for the day was 340.7 K. The trading history from January 29, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.14% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Rigel Pharmaceuticals to competition |
Other Forecasting Options for Rigel Pharmaceuticals
For every potential investor in Rigel, whether a beginner or expert, Rigel Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Rigel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Rigel. Basic forecasting techniques help filter out the noise by identifying Rigel Pharmaceuticals' price trends.Rigel Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rigel Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Rigel Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Rigel Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Rigel Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Rigel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rigel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rigel Pharmaceuticals stock market strength indicators, traders can identify Rigel Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 11564.07 | |||
| Daily Balance Of Power | (0.07) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 35.33 | |||
| Day Typical Price | 35.27 | |||
| Price Action Indicator | (0.22) | |||
| Period Momentum Indicator | (0.09) | |||
| Relative Strength Index | 45.16 |
Rigel Pharmaceuticals Risk Indicators
The analysis of Rigel Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rigel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rigel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.89 | |||
| Semi Deviation | 3.79 | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.47 | |||
| Downside Variance | 16.78 | |||
| Semi Variance | 14.38 | |||
| Expected Short fall | (5.33) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Rigel Pharmaceuticals
The number of cover stories for Rigel Pharmaceuticals depends on current market conditions and Rigel Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rigel Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rigel Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Rigel Pharmaceuticals Short Properties
Rigel Pharmaceuticals' future price predictability will typically decrease when Rigel Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Rigel Pharmaceuticals often depends not only on the future outlook of the potential Rigel Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rigel Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 17.7 M | |
| Cash And Short Term Investments | 77.3 M |
Check out Historical Fundamental Analysis of Rigel Pharmaceuticals to cross-verify your projections. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. Anticipated expansion of Rigel directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Rigel Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 1.086 | Earnings Share 6.19 | Revenue Per Share | Quarterly Revenue Growth 0.256 | Return On Assets |
Investors evaluate Rigel Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Rigel Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Rigel Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Rigel Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rigel Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Rigel Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.